These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. Nilsson CL; Brinkmalm A; Minthon L; Blennow K; Ekman R Peptides; 2001 Dec; 22(12):2105-12. PubMed ID: 11786197 [TBL] [Abstract][Full Text] [Related]
36. Recent advances in the neurochemical pathology of Alzheimer's disease. Studies of neuropeptides, cholinergic function and Alzheimer's disease-associated protein. Nemeroff CB; Bissette G; Slotkin TA; Seidler FJ; Miller BE; Ghanbari H Ann N Y Acad Sci; 1991; 640():193-6. PubMed ID: 1685644 [TBL] [Abstract][Full Text] [Related]
37. Neuropeptides in relation to suicidal behavior in depression. Roy A Neuropsychobiology; 1993; 28(4):184-6. PubMed ID: 7903797 [TBL] [Abstract][Full Text] [Related]
38. CSF neurochemical study of tardive dyskinesia. Lu RB; Ko HC; Lin WL; Lin YT; Ho SL Biol Psychiatry; 1989 Mar; 25(6):717-24. PubMed ID: 2466490 [TBL] [Abstract][Full Text] [Related]
39. Different patterns of CSF neurotransmitter metabolism in patients with left or right hemispheric stroke. Ferrarese C; Bassi S; Frattola L; Locatelli P; Piolti R; Trabucchi M Acta Neurol Scand; 1986 Jun; 73(6):581-5. PubMed ID: 2428200 [TBL] [Abstract][Full Text] [Related]
40. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity? Scheinin M Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]